{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:47:56Z","timestamp":1777927676452,"version":"3.51.4"},"reference-count":145,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The complex etiology and limited therapy options of neurodegenerative illnesses pose\ndaunting challenges to modern medicine. Nonetheless, novel treatment approaches have exciting\nnew possibilities because of developments in nanotechnology. Liposomes have garnered a lot of\ninterest as a potential treatment for neurological illnesses due to the fact that they are able to adapt\nto their role as nanocarriers. This review article discusses various uses of liposomes, including\ntheir ability to help treat neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's\ndisease, as well as their diagnostic and neuroprotective uses. Liposomes allow for the targeted\ndelivery of medicines to specific brain areas with minimal systemic side effects since they\nencapsulate and carry therapeutic molecules across the blood-brain barrier. Due to the fact that\nthey are biocompatible, have surface features that can be adjusted, and have the ability to co-deliver\nmany drugs, liposomes are excellent candidates for combination therapy and personalized\nmedicine procedures. In spite of this, there is a growing body of research that suggests liposomes\ncould serve as a versatile platform for the improvement of neurodegenerative disease treatment.\nThis is a positive sign for the future results of patients and their quality of life.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118715249342585241230065557","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T02:57:51Z","timestamp":1738292271000},"page":"496-512","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of Liposomes in the Treatment of Neurodegenerative Disorders: A Comprehensive Review"],"prefix":"10.2174","volume":"25","author":[{"given":"Nitika","family":"Garg","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchit","family":"Dhankhar","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankush","family":"Dhariya","sequence":"additional","affiliation":[{"name":"Ganpati Institute of Pharmacy,\nBilaspur, 135102, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chander","family":"Parkash","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrat","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"111511","DOI":"10.1016\/j.envres.2021.111511","volume":"201","author":"Bongioanni P.","year":"2021","unstructured":"Bongioanni P.; Del Carratore R.; Corbianco S.; Diana A.; Cavallini G.; Masciandaro S.M.; Dini M.; Buizza R.; Climate change and neurodegenerative diseases. Environ Res  2021,201,111511","journal-title":"Environ Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/ijms22031413","volume":"22","author":"Behl T.","year":"2021","unstructured":"Behl T.; Kaur G.; Sehgal A.; Bhardwaj S.; Singh S.; Buhas C.; Judea-Pusta C.; Uivarosan D.; Munteanu M.A.; Bungau S.; Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives. Int J Mol Sci  2021,22(3),1413","journal-title":"Int J Mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Hou Y.","year":"2019","unstructured":"Hou Y.; Dan X.; Babbar M.; Wei Y.; Hasselbalch S.G.; Croteau D.L.; Bohr V.A.; Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol  2019,15(10),565-581","journal-title":"Nat Rev Neurol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","volume":"15","author":"Bhattacharya T.","year":"2022","unstructured":"Bhattacharya T.; Soares G.A.B.; Chopra H.; Rahman M.M.; Hasan Z.; Swain S.S.; Cavalu S.; Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials  2022,15(3),804","journal-title":"Materials"},{"key":"ref=5","author":"Poddar M.K.","year":"2021","unstructured":"Poddar M.K.; Chakraborty A.; Banerjee S.;  Neurodegeneration: Diagnosis, prevention, and therapy  2021","journal-title":"Neurodegeneration: Diagnosis, prevention, and therapy"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/ph17060701","volume":"17","author":"Kciuk M.","year":"2024","unstructured":"Kciuk M.; Garg N.; Dhankhar S.; Saini M.; Mujwar S.; Devi S.; Chauhan S.; Singh T.G.; Singh R.; Marciniak B.; Gieleci\u0144ska A.; Kontek R.; Exploring the comprehensive neuroprotective and anticancer potential of afzelin. Pharmaceuticals  2024,17(6),701","journal-title":"Pharmaceuticals"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1242\/dmm.030205","volume":"10","author":"Gitler A.D.","year":"2017","unstructured":"Gitler A.D.; Dhillon P.; Shorter J.; Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech  2017,10(5),499-502","journal-title":"Dis Model Mech"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/brainsci9020034","volume":"9","author":"Buckley C.","year":"2019","unstructured":"Buckley C.; Alcock L.; McArdle R.; Rehman R.; Del Din S.; Mazz\u00e0 C.; Yarnall A.; Rochester L.; The role of movement analysis in diagnosing and monitoring neurodegenerative conditions: Insights from gait and postural control. Brain Sci  2019,9(2),34","journal-title":"Brain Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.2174\/138920112803341761","volume":"13","author":"Garbayo E.","year":"2012","unstructured":"Garbayo E.; Ansorena E.; Blanco-Prieto M.J.; Brain drug delivery systems for neurodegenerative disorders. Curr Pharm Biotechnol  2012,13(12),2388-2402","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"Cunnane S.C.","year":"2020","unstructured":"Cunnane S.C.; Trushina E.; Morland C.; Prigione A.; Casadesus G.; Andrews Z.B.; Beal M.F.; Bergersen L.H.; Brinton R.D.; de la Monte S.; Eckert A.; Harvey J.; Jeggo R.; Jhamandas J.H.; Kann O.; la Cour C.M.; Martin W.F.; Mithieux G.; Moreira P.I.; Murphy M.P.; Nave K.A.; Nuriel T.; Oliet S.H.R.; Saudou F.; Mattson M.P.; Swerdlow R.H.; Millan M.J.; Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov  2020,19(9),609-633","journal-title":"Nat Rev Drug Discov"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1080\/10717544.2016.1177136","volume":"23","author":"Zylberberg C.","year":"2016","unstructured":"Zylberberg C.; Matosevic S.; Pharmaceutical liposomal drug delivery: A review of new delivery systems and a look at the regulatory landscape. Drug Deliv  2016,23(9),3319-3329","journal-title":"Drug Deliv"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","volume":"67","author":"Cohen-Pfeffer J.L.","year":"2017","unstructured":"Cohen-Pfeffer J.L.; Gururangan S.; Lester T.; Lim D.A.; Shaywitz A.J.; Westphal M.; Slavc I.; Intracerebroventricular delivery as a safe, long-term route of drug administration. Pediatr Neurol  2017,67,23-35","journal-title":"Pediatr Neurol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/ijms15021719","volume":"15","author":"Wyse R.","year":"2014","unstructured":"Wyse R.; Dunbar G.; Rossignol J.; Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases. Int J Mol Sci  2014,15(2),1719-1745","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s10787-024-01526-8","volume":"32","author":"Tiwari C.","year":"2024","unstructured":"Tiwari C.; Khan H.; Grewal A.K.; Dhankhar S.; Chauhan S.; Dua K.; Gupta G.; Singh T.G.; Opiorphin: An endogenous human peptide with intriguing application in diverse range of pathologies. Inflammopharmacology  2024,32(5),3037-3056","journal-title":"Inflammopharmacology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S117210","volume":"11","author":"Vieira D.","year":"2016","unstructured":"Vieira D.; Gamarra L.; Getting into the brain: Liposome-based strategies for effective drug delivery across the blood\u2013brain barrier. Int J Nanomedicine  2016,11,5381-5414","journal-title":"Int J Nanomedicine"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"20140459","DOI":"10.1098\/rsif.2014.0459","volume":"11","author":"Monteiro N.","year":"2014","unstructured":"Monteiro N.; Martins A.; Reis R.L.; Neves N.M.; Liposomes in tissue engineering and regenerative medicine. J R Soc Interface  2014,11(101),20140459","journal-title":"J R Soc Interface"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tifs.2019.01.013","volume":"85","author":"Islam Shishir M.R.","year":"2019","unstructured":"Islam Shishir M.R.; Karim N.; Gowd V.; Zheng X.; Chen W.; Liposomal delivery of natural product: A promising approach in health research. Trends Food Sci Technol  2019,85,177-200","journal-title":"Trends Food Sci Technol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/polym15030782","volume":"15","author":"Pasarin D.","year":"2023","unstructured":"Pasarin D.; Ghizdareanu A.I.; Enascuta C.E.; Matei C.B.; Bilbie C.; Paraschiv-Palada L.; Veres P.A.; Coating materials to increase the stability of liposomes. Polymers  2023,15(3),782","journal-title":"Polymers"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"Nsairat H.","year":"2022","unstructured":"Nsairat H.; Khater D.; Sayed U.; Odeh F.; Al Bawab A.; Alshaer W.; Liposomes: Structure, composition, types, and clinical applications. Heliyon  2022,8(5),e09394","journal-title":"Heliyon"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2018.02.002","volume":"253","author":"McClements D.J.","year":"2018","unstructured":"McClements D.J.; Encapsulation, protection, and delivery of bioactive proteins and peptides using nanoparticle and microparticle systems: A review. Adv Colloid Interface Sci  2018,253,1-22","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e202104045","DOI":"10.1002\/slct.202104045","volume":"7","author":"Joy R.","year":"2022","unstructured":"Joy R.; George J.; John F.; Brief outlook on polymeric nanoparticles, micelles, niosomes, hydrogels and liposomes: Preparative methods and action. ChemistrySelect  2022,7(6),e202104045","journal-title":"ChemistrySelect"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","volume":"164","author":"Li M.","year":"2019","unstructured":"Li M.; Du C.; Guo N.; Teng Y.; Meng X.; Sun H.; Li S.; Yu P.; Galons H.; Composition design and medical application of liposomes. Eur J Med Chem  2019,164,640-653","journal-title":"Eur J Med Chem"},{"key":"ref=23","volume":"4","author":"Yusaf R.","year":"2014","unstructured":"Yusaf R.; Structural components of liposomes and characterization tools. American Journal of Pharm Research  2014,4(08)","journal-title":"American Journal of Pharm Research"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1572-5995(08)80027-0","volume":"134","author":"Hatziantonioy S.","year":"2008","unstructured":"Hatziantonioy S.; Demetzos C.; Lipids of membranes: Chemistry, biological role and applications as drug carriers. Studies in natural products chemistry  2008,134,173-202","journal-title":"Studies in natural products chemistry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/ejlt.201400219","volume":"116","author":"van Hoogevest P.","year":"2014","unstructured":"van Hoogevest P.; Wendel A.; The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur J Lipid Sci Technol  2014,116(9),1088-1107","journal-title":"Eur J Lipid Sci Technol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2174\/0115748855269071231113070552","volume":"19","author":"Sood R.","year":"2024","unstructured":"Sood R.; Tomar D.; Kaushik P.; Sharma P.; Rani N.; Guarve K.; Dhankhar S.; Garg N.; Enhanced solubility and increased bioavailability with engineered nanocrystals. Curr Drug Ther  2024,19(6),638-647","journal-title":"Curr Drug Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/pharmaceutics12121235","volume":"12","author":"Drescher S.","year":"2020","unstructured":"Drescher S.; van Hoogevest P.; The phospholipid research center: Current research in phospholipids and their use in drug delivery. Pharmaceutics  2020,12(12),1235","journal-title":"Pharmaceutics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.19103\/AS.2016.0012.03","author":"Roberts J.R.","year":"2017","unstructured":"Roberts J.R.; The nutritional and physiological functions of egg yolk components Yasumi Horimoto, University of Guelph, Canada and Hajime Hatta, Kyoto Women\u2019s University, Japan Achieving sustainable production of eggs Volume 1  2017,69-116","journal-title":"Achieving sustainable production of eggs Volume 1"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-9164-4_3","author":"Kalra J.","year":"2013","unstructured":"Kalra J.; Bally M.B.; Liposomes. Fundamentals of pharmaceutical nanoscience  2013,27-63","journal-title":"Fundamentals of pharmaceutical nanoscience"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"705886","DOI":"10.3389\/fbioe.2021.705886","volume":"9","author":"Nakhaei P.","year":"2021","unstructured":"Nakhaei P.; Margiana R.; Bokov D.O.; Abdelbasset W.K.; Jadidi Kouhbanani M.A.; Varma R.S.; Marofi F.; Jarahian M.; Beheshtkhoo N.; Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol. Front Bioeng Biotechnol  2021,9,705886","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=31","first-page":"405","author":"Liu R.R.","year":"2018","unstructured":"Liu R.R.; Cannon J.B.; Paspal S.Y.;  Water-Insoluble Drug Formulation  2018,405-449","journal-title":"Water-Insoluble Drug Formulation"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pharmaceutics13050763","volume":"13","author":"Mollinedo F.","year":"2021","unstructured":"Mollinedo F.; Gajate C.; Mitochondrial targeting involving cholesterol-rich lipid rafts in the mechanism of action of the antitumor ether lipid and alkylphospholipid analog edelfosine. Pharmaceutics  2021,13(5),763","journal-title":"Pharmaceutics"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ijpharm.2012.07.050","volume":"436","author":"Mo L.","year":"2012","unstructured":"Mo L.; Hou L.; Guo D.; Xiao X.; Mao P.; Yang X.; Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Int J Pharm  2012,436(1-2),815-824","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"106267","DOI":"10.1016\/j.ejps.2022.106267","volume":"177","author":"Hols\u00e6ter A.M.","year":"2022","unstructured":"Hols\u00e6ter A.M.; Wizgird K.; Karlsen I.; Hemmingsen J.F.; Brandl M.; \u0160kalko-Basnet N.; How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition\u2013A formulation screening study. Eur J Pharm Sci  2022,177,106267","journal-title":"Eur J Pharm Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-981-97-0542-9_6","author":"Mittal P.","year":"2024","unstructured":"Mittal P.; Sharma H.; Kapoor R.; Gautam R.K.; Garg N.; Dhankhar S.; Biobased Nanomaterials in Biomedical Applications. Biobased Nanomaterials: Applications in Biomedicine, Food Industry, Agriculture, and Environmental Sustainability  2024,141-171","journal-title":"Biobased Nanomaterials: Applications in Biomedicine, Food Industry, Agriculture, and Environmental Sustainability"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"127246","DOI":"10.1016\/j.colsurfa.2021.127246","volume":"627","author":"Rathod S.","year":"2021","unstructured":"Rathod S.; Arya S.; Shukla R.; Ray D.; Aswal V.K.; Bahadur P.; Tiwari S.; Investigations on the role of edge activator upon structural transitions in Span vesicles. Colloids Surf A Physicochem Eng Asp  2021,627,127246","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3797\/scipharm.1204-16","volume":"81","author":"Mudgil M.","year":"2013","unstructured":"Mudgil M.; Pawar P.K.; Preparation and in vitro\/ex vivo evaluation of moxifloxacin-loaded PLGA nanosuspensions for ophthalmic application. Sci Pharm  2013,81(2),591-606","journal-title":"Sci Pharm"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4314\/bcse.v27i2.7","volume":"27","author":"Welderfael T.","year":"2013","unstructured":"Welderfael T.; Yadav O.P.; Taddesse A.M.; Kaushal J.; Synthesis, characterization and photocatalytic activities of Ag-N-codoped ZnO nanoparticles for degradation of methyl red. Bull Chem Soc Ethiop  2013,27(2),221-232","journal-title":"Bull Chem Soc Ethiop"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.ijbiomac.2020.02.048","volume":"149","author":"Kumar A.","year":"2020","unstructured":"Kumar A.; Behl T.; Chadha S.; Synthesis of physically crosslinked PVA\/Chitosan loaded silver nanoparticles hydrogels with tunable mechanical properties and antibacterial effects. Int J Biol Macromol  2020,149,1262-1274","journal-title":"Int J Biol Macromol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1517\/17425247.2013.766714","volume":"10","author":"Lai F.","year":"2013","unstructured":"Lai F.; Fadda A.M.; Sinico C.; Liposomes for brain delivery. Expert Opin Drug Deliv  2013,10(7),1003-1022","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/2211738511666230309104323","volume":"11","author":"Sharma S.","year":"2023","unstructured":"Sharma S.; Kumari N.; Garg D.; Chauhan S.; A Compendium of Bioavailability Enhancement via Niosome Technology. Pharm Nanotechnol  2023,11(4),324-338","journal-title":"Pharm Nanotechnol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2012.12.013","volume":"166","author":"Naahidi S.","year":"2013","unstructured":"Naahidi S.; Jafari M.; Edalat F.; Raymond K.; Khademhosseini A.; Chen P.; Biocompatibility of engineered nanoparticles for drug delivery. J Control Release  2013,166(2),182-194","journal-title":"J Control Release"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/1061186X.2012.685477","volume":"20","author":"Silindir M.","year":"2012","unstructured":"Silindir M.; Erdo\u011fan S.; \u00d6zer A.Y.; Maia S.; Liposomes and their applications in molecular imaging. J Drug Target  2012,20(5),401-415","journal-title":"J Drug Target"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","volume":"260","author":"Agrawal M.","year":"2017","unstructured":"Agrawal M.; Ajazuddin ; Tripathi D.K.; Saraf S.; Saraf S.; Antimisiaris S.G.; Mourtas S.; Hammarlund-Udenaes M.; Alexander A.; Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease. J Control Release  2017,260,61-77","journal-title":"J Control Release"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1166\/jbn.2019.2837","volume":"15","author":"Formicola B.","year":"2019","unstructured":"Formicola B.; Cox A.; dal Magro R.; Masserini M.; Re F.; Nanomedicine for the Treatment of Alzheimer\u2019s Disease. J Biomed Nanotechnol  2019,15(10),1997-2024","journal-title":"J Biomed Nanotechnol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-3-030-78787-5_48","volume":"1339","author":"Naziris N.","year":"2021","unstructured":"Naziris N.; Demetzos C.; Production methods and application in Alzheimer\u2019s disease. Genet Neurodegen Dise  2021,1339,385-394","journal-title":"Genet Neurodegen Dise"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jconrel.2022.01.044","volume":"343","author":"Taliyan R.","year":"2022","unstructured":"Taliyan R.; Kakoty V.; Sarathlal K.C.; Kharavtekar S.S.; Karennanavar C.R.; Choudhary Y.K.; Singhvi G.; Riadi Y.; Dubey S.K.; Kesharwani P.; Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer\u2019s disease. J Control Release  2022,343,528-550","journal-title":"J Control Release"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/B978-0-443-15491-1.00006-7","author":"Agrawal M.","year":"2024","unstructured":"Agrawal M.; Singh S.; Alexander A.;  Liposomes in Drug Delivery  2024,243-262","journal-title":"Liposomes in Drug Delivery"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2019.03.001","volume":"245","author":"Tosi G.","year":"2019","unstructured":"Tosi G.; Pederzoli F.; Belletti D.; Vandelli M.A.; Forni F.; Duskey J.T.; Ruozi B.; Nanomedicine in Alzheimer\u2019s disease: Amyloid beta targeting strategy. Prog Brain Res  2019,245,1-32","journal-title":"Prog Brain Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.biomaterials.2010.10.027","volume":"32","author":"Mourtas S.","year":"2011","unstructured":"Mourtas S.; Canovi M.; Zona C.; Aurilia D.; Niarakis A.; La Ferla B.; Salmona M.; Nicotra F.; Gobbi M.; Antimisiaris S.G.; Curcumin-decorated nanoliposomes with very high affinity for amyloid-\u03b21-42 peptide. Biomaterials  2011,32(6),1635-1645","journal-title":"Biomaterials"},{"key":"ref=51","author":"Nunes D.S.S.","year":"2020","unstructured":"Nunes D.S.S.;  The use of natural compounds loaded into solid lipid nanoparticles for the alzheimer\u00b4 s disease therapy: A new therapeutic approach  2020","journal-title":"The use of natural compounds loaded into solid lipid nanoparticles for the alzheimer\u00b4 s disease therapy: A new therapeutic approach"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1016\/j.biomaterials.2011.04.020","volume":"32","author":"Canovi M.","year":"2011","unstructured":"Canovi M.; Markoutsa E.; Lazar A.N.; Pampalakis G.; Clemente C.; Re F.; Sesana S.; Masserini M.; Salmona M.; Duyckaerts C.; Flores O.; Gobbi M.; Antimisiaris S.G.; The binding affinity of anti-A\u03b21-42 MAb-decorated nanoliposomes to A\u03b21-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials  2011,32(23),5489-5497","journal-title":"Biomaterials"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.31557\/apjcb.2016.1.3.59-66","volume":"1","author":"Moradi-Sardareh H.","year":"2016","unstructured":"Moradi-Sardareh H.; Moradi M.; Bordbar E.; Malekpour M.; Bagheri S.; Nakhodazadeh N.; Rahbar S.; Farhadian Asgarabadi J.; The use of monoclonal antibodies in the treatment of alzheimer disease. Asian Pacific Journal of Cancer Biology  2016,1(3),59-66","journal-title":"Asian Pacific Journal of Cancer Biology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/cphc.202100124","volume":"22","author":"Andrade S.","year":"2021","unstructured":"Andrade S.; Loureiro J.A.; Pereira M.C.; The role of amyloid \u03b2\u2010biomembrane interactions in the pathogenesis of alzheimer\u2019s disease: Insights from liposomes as membrane models. ChemPhysChem  2021,22(15),1547-1565","journal-title":"ChemPhysChem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1042986","DOI":"10.3389\/fbioe.2022.1042986","volume":"10","author":"Vlamos P.","year":"2022","unstructured":"Vlamos P.; Kotsireas I.S.; Tarnanas I.; Applications of nanotechnology in alzheimer\u2019s disease. Front Bioeng Biotechnol  2022,10,1042986","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=56","first-page":"001","volume":"11","author":"Pathak K.","year":"2021","unstructured":"Pathak K.; Mishra S.K.; Porwal A.; Bahadur S.; Nanocarriers for Alzheimer\u2019s disease: Research and patent update. Journal of Applied Pharmaceutical Science  2021,11(3),001-21","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/B978-0-12-819838-4.00028-6","author":"Bhatt T.","year":"2021","unstructured":"Bhatt T.; Patel B.M.; Patel M.M.; Parkinson\u2019s disease. Drug Delivery Devices and Therapeutic Systems  2021,491-513","journal-title":"Drug Delivery Devices and Therapeutic Systems"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ph16070908","volume":"16","author":"Mittal P.","year":"2023","unstructured":"Mittal P.; Dhankhar S.; Chauhan S.; Garg N.; Bhattacharya T.; Ali M.; Chaudhary A.A.; Rudayni H.A.; Al-Zharani M.; Ahmad W.; Khan S.U.D.; Singh T.G.; Mujwar S.; A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson\u2019s Disease. Pharmaceuticals  2023,16(7),908","journal-title":"Pharmaceuticals"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e230823220256","DOI":"10.2174\/2211352521666230823122601","volume":"22","author":"Narwal S.","year":"2024","unstructured":"Narwal S.; Dhanda T.; Sharma P.; Sharma V.; Dhankhar S.; Garg N.; Ghosh N.S.; Rani N.; Current therapeutic strategies for chagas disease. Anti-infect Agents  2024,22(2),e230823220256","journal-title":"Anti-infect Agents"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.procbio.2021.08.008","volume":"110","author":"Singh A.","year":"2021","unstructured":"Singh A.; Maharana S.K.; Shukla R.; Kesharwani P.; Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochem  2021,110,181-194","journal-title":"Process Biochem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/s41380-020-0742-4","volume":"26","author":"Kahana M.","year":"2021","unstructured":"Kahana M.; Weizman A.; Gabay M.; Loboda Y.; Segal-Gavish H.; Gavish A.; Barhum Y.; Offen D.; Finberg J.; Allon N.; Gavish M.; Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson\u2019s disease. Mol Psychiatry  2021,26(6),2626-2632","journal-title":"Mol Psychiatry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"102793","DOI":"10.1016\/j.jddst.2021.102793","volume":"66","author":"Shankar J.","year":"2021","unstructured":"Shankar J.; Geetha K.; Wilson B.; Potential applications of nanomedicine for treating Parkinson\u2019s disease. J Drug Deliv Sci Technol  2021,66,102793","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"380","DOI":"10.18006\/2023.11(2).380.393","volume":"11","author":"Ahmed M.S.","year":"2023","unstructured":"Ahmed M.S.; Khan I.J.; Aman S.; Chauhan S.; Kaur N.; Shriwastav S.; Goel K.; Saini M.; Dhankar S.; Singh T.G.; Dev J.; Mujwar S.; Phytochemical investigations, in-vitro antioxidant, antimicrobial potential, and in-silico computational docking analysis of Euphorbia milii Des Moul. J Exp Biol Agric Sci Phytochemical investigations 2023,11(2),380-393","journal-title":"J Exp Biol Agric Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.onano.2022.100111","volume":"9","author":"Bhosale A.","year":"2023","unstructured":"Bhosale A.; Paul G.; Mazahir F.; Yadav A.K.; Theoretical and applied concepts of nanocarriers for the treatment of Parkinson\u2019s diseases. OpenNano  2023,9,100111","journal-title":"OpenNano"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"119704","DOI":"10.1016\/j.biomaterials.2019.119704","volume":"232","author":"Karthivashan G.","year":"2020","unstructured":"Karthivashan G.; Ganesan P.; Park S.Y.; Lee H.W.; Choi D.K.; Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson\u2019s disease: From preclinical to translational studies. Biomaterials  2020,232,119704","journal-title":"Biomaterials"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e09575","DOI":"10.1016\/j.heliyon.2022.e09575","volume":"8","author":"Pandian S.R.K.","year":"2022","unstructured":"Pandian S.R.K.; Vijayakumar K.K.; Murugesan S.; Kunjiappan S.; Liposomes: An emerging carrier for targeting Alzheimer\u2019s and Parkinson\u2019s diseases. Heliyon  2022,8(6),e09575","journal-title":"Heliyon"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/B978-0-12-817909-3.00014-5","author":"Soni V.","year":"2019","unstructured":"Soni V.;  Basic Fundamentals of Drug Delivery  2019,539-593","journal-title":"Basic Fundamentals of Drug Delivery"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13098-023-00983-5","volume":"15","author":"Dhankhar S.","year":"2023","unstructured":"Dhankhar S.; Chauhan S.; Mehta D.K.; Nitika ; Saini K.; Saini M.; Das R.; Gupta S.; Gautam V.; Novel targets for potential therapeutic use in Diabetes mellitus. Diabetol Metab Syndr  2023,15(1),17","journal-title":"Diabetol Metab Syndr"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/0122115501303253240408072559","volume":"13","author":"Dhankhar S.","year":"2024","unstructured":"Dhankhar S.; Garg N.; Chauhan S.; Saini M.; Role of artificial intelligence in diabetic wound screening and early detection. Curr Biotechnol  2024,13(2),93-106","journal-title":"Curr Biotechnol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"115881","DOI":"10.1016\/j.biopha.2023.115881","volume":"169","author":"Rohilla M.","year":"2023","unstructured":"Rohilla M.; Rishabh ; Bansal S.; Garg A.; Dhiman S.; Dhankhar S.; Saini M.; Chauhan S.; Alsubaie N.; Batiha G.E.S.; Albezrah N.K.A.; Singh T.G.; Discussing pathologic mechanisms of diabetic retinopathy and therapeutic potentials of curcumin and \u03b2-glucogallin in the management of diabetic retinopathy. Biomed Pharmacother  2023,169,115881","journal-title":"Biomed Pharmacother"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e02506882253706","DOI":"10.2174\/0102506882253706240104073440","volume":"5","author":"Rohilla S.","year":"2024","unstructured":"Rohilla S.; Sharma P.; Kamboj S.; Dhankhar S.; Garg N.; Chauhan S.; Rani N.; Anabolic androgenic steroids: A review. Emir Med J  2024,5,e02506882253706","journal-title":"Emir Med J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","volume":"62","author":"Smeyne M.","year":"2013","unstructured":"Smeyne M.; Smeyne R.J.; Glutathione metabolism and Parkinson\u2019s disease. Free Radic Biol Med  2013,62,13-25","journal-title":"Free Radic Biol Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/ijnpnd.ijnpnd_13_21","volume":"11","author":"Chauhan S.","year":"2021","unstructured":"Chauhan S.; Gupta S.; Yasmin S.; Saini M.; Antihyperglycemic and antioxidant potential of plant extract of litchi chinensis and glycine max. Int J Nutr Pharmacol Neurol Dis  2021,11(3),225-233","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"120955","DOI":"10.1016\/j.biomaterials.2021.120955","volume":"275","author":"Nguyen A.","year":"2021","unstructured":"Nguyen A.; B\u00f6ttger R.; Li S.D.; Recent trends in bioresponsive linker technologies of prodrug-based self-assembling nanomaterials. Biomaterials  2021,275,120955","journal-title":"Biomaterials"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115734137299120240312044808","volume":"20","author":"Dhankar S.","year":"2024","unstructured":"Dhankar S.; Garg N.; Chauhan S.; Saini M.; A bird view on the role of graphene oxide nanosystems in therapeutic delivery. Curr Nanosci  2024,20,1-11","journal-title":"Curr Nanosci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"682597","DOI":"10.3389\/fncel.2021.682597","volume":"15","author":"Bondarenko O.","year":"2021","unstructured":"Bondarenko O.; Saarma M.; Neurotrophic factors in Parkinson\u2019s disease: clinical trials, open challenges and nanoparticle-mediated delivery to the brain. Front Cell Neurosci  2021,15,682597","journal-title":"Front Cell Neurosci"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/2666082219666230320153841","volume":"20","author":"Dhankhar S.","year":"2024","unstructured":"Dhankhar S.; Cognitive rehabilitation for early-stage dementia: A review. Curr Psychiatry Res Rev  2024,20,1-14","journal-title":"Curr Psychiatry Res Rev"},{"key":"ref=78","first-page":"1734","volume":"3","author":"Lalit K.","year":"2014","unstructured":"Lalit K.; Phyto-pharmacological review of Coccinia indica. World J Pharm Pharm Sci  2014,3(2),1734-1745","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.2174\/1381612826666200128145124","volume":"26","author":"Kumar B.","year":"2020","unstructured":"Kumar B.; Pandey M.; Pottoo F.H.; Fayaz F.; Sharma A.; Sahoo P.K.; Liposomes: Novel drug delivery approach for targeting Parkinson\u2019s disease. Curr Pharm Des  2020,26(37),4721-4737","journal-title":"Curr Pharm Des"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/0118715273266095231009092603","volume":"23","author":"Dhankhar S.","year":"2024","unstructured":"Dhankhar S.; Mujwar S.; Garg N.; Chauhan S.; Saini M.; Sharma P.; Kumar S.; Kumar Sharma S.; Kamal M.A.; Rani N.; Artificial intelligence in the management of neurodegenerative disorders. CNS Neurol Disord Drug Targets  2024,23(8),931-940","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"Tabrizi S.J.","year":"2020","unstructured":"Tabrizi S.J.; Flower M.D.; Ross C.A.; Wild E.J.; Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol  2020,16(10),529-546","journal-title":"Nat Rev Neurol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"104774","DOI":"10.1016\/j.jddst.2023.104774","volume":"87","author":"Mustafa G.","year":"2023","unstructured":"Mustafa G.; Hassan D.; Zeeshan M.; Ruiz-Pulido G.; Ebrahimi N.; Mobashar A.; Pourmadadi M.; Rahdar A.; Sargazi S.; Fathi-karkan S.; Medina D.I.; D\u00edez-Pascual A.M.; Advances in nanotechnology versus stem cell therapy for the theranostics of huntington\u2019s disease. J Drug Deliv Sci Technol  2023,87,104774","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=83","first-page":"1","author":"Lata J.M.G.","year":"2020","unstructured":"Lata J.M.G.;  The role of nanotechnology to overcome the natural compounds limitations in the treatment of Alzheimer's and Huntington's diseases  2020,1-32","journal-title":"The role of nanotechnology to overcome the natural compounds limitations in the treatment of Alzheimer's and Huntington's diseases"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"e02506882282929","DOI":"10.2174\/0102506882282929231212074538","volume":"5","author":"Panchal M.","year":"2024","unstructured":"Panchal M.; Rana P.; Garg N.; Dhankhar S.; Sharma H.; Chauhan S.; A Comprehensive review of alternative therapeutic approaches for nausea and vomiting relief in pregnancy. Emir Med J  2024,5,e02506882282929","journal-title":"Emir Med J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2174\/0122117385266276230928064235","volume":"12","author":"Saharan R.","year":"2024","unstructured":"Saharan R.; Kaur J.; Dhankhar S.; Garg N.; Chauhan S.; Beniwal S.; Sharma H.; Hydrogel-based drug delivery system in diabetes management. Pharm Nanotechnol  2024,12(4),289-299","journal-title":"Pharm Nanotechnol"},{"key":"ref=86","first-page":"10","volume":"4","author":"Chauhan S.","year":"2015","unstructured":"Chauhan S.; Kishore L.; Kaur N.; Singh R.; Potential anti-arthritic agents from indian medicinal plants. Res Rev J Pharm Pharm Sci  2015,4(3),10-22","journal-title":"Res Rev J Pharm Pharm Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"106823","DOI":"10.1016\/j.phrs.2023.106823","volume":"194","author":"Birolini G.","year":"2023","unstructured":"Birolini G.; Valenza M.; Ottonelli I.; Talpo F.; Minoli L.; Cappelleri A.; Bombaci M.; Caccia C.; Canevari C.; Trucco A.; Leoni V.; Passoni A.; Favagrossa M.; Nucera M.R.; Colombo L.; Paltrinieri S.; Bagnati R.; Duskey J.T.; Caraffi R.; Vandelli M.A.; Taroni F.; Salmona M.; Scanziani E.; Biella G.; Ruozi B.; Tosi G.; Cattaneo E.; Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington\u2019s disease. Pharmacol Res  2023,194,106823","journal-title":"Pharmacol Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1021\/acschemneuro.9b00581","volume":"11","author":"Passoni A.","year":"2020","unstructured":"Passoni A.; Favagrossa M.; Colombo L.; Bagnati R.; Gobbi M.; Diomede L.; Birolini G.; Di Paolo E.; Valenza M.; Cattaneo E.; Salmona M.; Efficacy of cholesterol nose-to-brain delivery for brain targeting in Huntington\u2019s disease. ACS Chem Neurosci  2020,11(3),367-372","journal-title":"ACS Chem Neurosci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0122117385291530240305044703","volume":"12","author":"Sharma H.","year":"2024","unstructured":"Sharma H.; Garg N.; Dhankhar S.; MIttal P.; Chauhan S.; Saini M.; Biobased nanomaterials: Pioneering innovations for biomedical advancements. Pharm Nanotechnol  2024,12,1-15","journal-title":"Pharm Nanotechnol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1039\/D1BM01202A","volume":"9","author":"Marino A.","year":"2021","unstructured":"Marino A.; Battaglini M.; Desii A.; Lavarello C.; Genchi G.; Petretto A.; Ciofani G.; Liposomes loaded with polyphenol-rich grape pomace extracts protect from neurodegeneration in a rotenone-based in vitro model of Parkinson\u2019s disease. Biomater Sci  2021,9(24),8171-8188","journal-title":"Biomater Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/0118764029295903240328054858","volume":"16","author":"Sharma P.","year":"2024","unstructured":"Sharma P.; Kaushik P.; Kumar Sharma S.; Dhankhar S.; Garg N.; Rani N.; Exploring microsponges in dermatology: Opportunities and hurdles ahead. Micro Nanosyst  2024,16(2),65-74","journal-title":"Micro Nanosyst"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"120156","DOI":"10.1016\/j.lfs.2021.120156","volume":"288","author":"Dhasmana S.","year":"2022","unstructured":"Dhasmana S.; Dhasmana A.; Narula A.S.; Jaggi M.; Yallapu M.M.; Chauhan S.C.; The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sci  2022,288,120156","journal-title":"Life Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/antiox11020408","volume":"11","author":"Ashok A.","year":"2022","unstructured":"Ashok A.; Andrabi S.S.; Mansoor S.; Kuang Y.; Kwon B.K.; Labhasetwar V.; Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: Role of nanoparticle-based drug delivery systems in clinical translation. Antioxidants  2022,11(2),408","journal-title":"Antioxidants"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.drudis.2018.11.001","volume":"24","author":"Wang Z.Y.","year":"2019","unstructured":"Wang Z.Y.; Sreenivasmurthy S.G.; Song J.X.; Liu J.Y.; Li M.; Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discov Today  2019,24(2),595-605","journal-title":"Drug Discov Today"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4236\/anp.2012.13007","volume":"1","author":"Wiley N.J.","year":"2012","unstructured":"Wiley N.J.; Madhankumar A.B.; Mitchell R.M.; Neely E.B.; Rizk E.; Douds G.L.; Simmons Z.; Connor J.R.; Lipopolysaccharide modified liposomes for amyotropic lateral sclerosis therapy: Efficacy in SOD1 mouse model. Advances in Nanoparticles  2012,1(03),44-53","journal-title":"Advances in Nanoparticles"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbrc.2012.01.026","volume":"418","author":"Lee J.C.","year":"2012","unstructured":"Lee J.C.; Seong J.; Kim S.H.; Lee S.J.; Cho Y.J.; An J.; Nam D.H.; Joo K.M.; Cha C.I.; Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1G93A transgenic mice as an in vivo model of amyotrophic lateral sclerosis. Biochem Biophys Res Commun  2012,418(2),359-365","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","volume":"120","author":"Yang T.","year":"2018","unstructured":"Yang T.; Ferrill L.; Gallant L.; McGillicuddy S.; Fernandes T.; Schields N.; Bai S.; Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis. Eur J Pharm Sci  2018,120,30-39","journal-title":"Eur J Pharm Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2174\/1389200211314060001","volume":"14","author":"Pinz\u00f3n-Daza M.","year":"2013","unstructured":"Pinz\u00f3n-Daza M.; Campia I.; Kopecka J.; Garz\u00f3n R.; Ghigo D.; Rigant C.; Nanoparticle- and liposome-carried drugs: New strategies for active targeting and drug delivery across blood-brain barrier. Curr Drug Metab  2013,14(6),625-640","journal-title":"Curr Drug Metab"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"113142","DOI":"10.1016\/j.intimp.2024.113142","volume":"142","author":"Soni D.","year":"2024","unstructured":"Soni D.; Khan H.; Chauhan S.; Kaur A.; Dhankhar S.; Garg N.; Singh T.G.; Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases. Int Immunopharmacol  2024,142(Pt B),113142","journal-title":"Int Immunopharmacol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1389200217666160629112717","volume":"17","author":"Yang X.","year":"2016","unstructured":"Yang X.; Liu K.; P-gp inhibition-based strategies for modulating pharmacokinetics of anticancer drugs: An update. Curr Drug Metab  2016,17(8),806-826","journal-title":"Curr Drug Metab"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"Bulbake U.","year":"2017","unstructured":"Bulbake U.; Doppalapudi S.; Kommineni N.; Khan W.; Liposomal formulations in clinical use: An updated review. Pharmaceutics  2017,9(2),12","journal-title":"Pharmaceutics"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/B978-0-12-819666-3.00020-1","author":"Yadav K.","year":"2020","unstructured":"Yadav K.; Commercial aspects and market potential of novel delivery systems for bioactives and biological agents. Advances and avenues in the development of novel carriers for bioactives and biological agents  2020,595-620","journal-title":"Advances and avenues in the development of novel carriers for bioactives and biological agents"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","volume":"31","author":"Patel M.M.","year":"2017","unstructured":"Patel M.M.; Patel B.M.; Crossing the blood\u2013brain barrier: recent advances in drug delivery to the brain. CNS Drugs  2017,31(2),109-133","journal-title":"CNS Drugs"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1602\/neurorx.2.1.99","volume":"2","author":"Schnyder A.","year":"2005","unstructured":"Schnyder A.; Huwyler J.; Drug transport to brain with targeted liposomes. NeuroRx  2005,2(1),99-107","journal-title":"NeuroRx"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"114619","DOI":"10.1016\/j.addr.2022.114619","volume":"191","author":"Liu H.J.","year":"2022","unstructured":"Liu H.J.; Xu P.; Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor. Adv Drug Deliv Rev  2022,191,114619","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","volume":"37","author":"Ding S.","year":"2020","unstructured":"Ding S.; Khan A.I.; Cai X.; Song Y.; Lyu Z.; Du D.; Dutta P.; Lin Y.; Overcoming blood\u2013brain barrier transport: Advances in nanoparticle-based drug delivery strategies. Mater Today  2020,37,112-125","journal-title":"Mater Today"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","volume":"161","author":"Lammers T.","year":"2012","unstructured":"Lammers T.; Kiessling F.; Hennink W.E.; Storm G.; Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. J Control Release  2012,161(2),175-187","journal-title":"J Control Release"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.2174\/1381612823999171012102230","volume":"23","author":"Miyazaki I.","year":"2017","unstructured":"Miyazaki I.; Asanuma M.; Therapeutic strategy of targeting astrocytes for neuroprotection in Parkinson\u2019s disease. Curr Pharm Des  2017,23(33),4936-4947","journal-title":"Curr Pharm Des"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/10611860802228350","volume":"16","author":"Gregoriadis G.","year":"2008","unstructured":"Gregoriadis G.; Liposome research in drug delivery: The early days. J Drug Target  2008,16(7-8),520-524","journal-title":"J Drug Target"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1038\/ncomms6316","volume":"5","author":"Fieblinger T.","year":"2014","unstructured":"Fieblinger T.; Graves S.M.; Sebel L.E.; Alcacer C.; Plotkin J.L.; Gertler T.S.; Chan C.S.; Heiman M.; Greengard P.; Cenci M.A.; Surmeier D.J.; Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat Commun  2014,5(1),5316","journal-title":"Nat Commun"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/pharmaceutics10040181","volume":"10","author":"Mendes M.","year":"2018","unstructured":"Mendes M.; Sousa J.J.; Pais A.; Vitorino C.; Targeted theranostic nanoparticles for brain tumor treatment. Pharmaceutics  2018,10(4),181","journal-title":"Pharmaceutics"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/antiox9100998","volume":"9","author":"Borges A.","year":"2020","unstructured":"Borges A.; de Freitas V.; Mateus N.; Fernandes I.; Oliveira J.; Solid lipid nanoparticles as carriers of natural phenolic compounds. Antioxidants  2020,9(10),998","journal-title":"Antioxidants"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.nano.2016.10.006","volume":"13","author":"Gregori M.","year":"2017","unstructured":"Gregori M.; Taylor M.; Salvati E.; Re F.; Mancini S.; Balducci C.; Forloni G.; Zambelli V.; Sesana S.; Michael M.; Michail C.; Tinker-Mill C.; Kolosov O.; Sherer M.; Harris S.; Fullwood N.J.; Masserini M.; Allsop D.; Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer\u2019s A\u03b2 peptide. Nanomedicine  2017,13(2),723-732","journal-title":"Nanomedicine"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","volume":"9","author":"Huang M.","year":"2015","unstructured":"Huang M.; Hu M.; Song Q.; Song H.; Huang J.; Gu X.; Wang X.; Chen J.; Kang T.; Feng X.; Jiang D.; Zheng G.; Chen H.; Gao X.; GM1-modified lipoprotein-like nanoparticle: Multifunctional nanoplatform for the combination therapy of Alzheimer\u2019s disease. ACS Nano  2015,9(11),10801-10816","journal-title":"ACS Nano"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1570159X18666200106155127","volume":"18","author":"Rebas E.","year":"2020","unstructured":"Rebas E.; Rzajew J.; Radzik T.; Zylinska L.; Neuroprotective polyphenols: A modulatory action on neurotransmitter pathways. Curr Neuropharmacol  2020,18(5),431-445","journal-title":"Curr Neuropharmacol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.xphs.2022.02.005","volume":"111","author":"Di Battista V.","year":"2022","unstructured":"Di Battista V.; Hey-Hawkins E.; Development of prodrugs for treatment of parkinson\u2019s disease: New inorganic scaffolds for blood\u2013brain barrier permeation. J Pharm Sci  2022,111(5),1262-1279","journal-title":"J Pharm Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"e1898","DOI":"10.1002\/wnan.1898","volume":"15","author":"Hernando S.","year":"2023","unstructured":"Hernando S.; Santos-Vizca\u00edno E.; Igartua M.; Hernandez R.M.; Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles\u2014Focus on Alzheimer\u2019s and Parkinson\u2019s disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol  2023,15(5),e1898","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1021\/nn506408v","volume":"9","author":"Pahuja R.","year":"2015","unstructured":"Pahuja R.; Seth K.; Shukla A.; Shukla R.K.; Bhatnagar P.; Chauhan L.K.S.; Saxena P.N.; Arun J.; Chaudhari B.P.; Patel D.K.; Singh S.P.; Shukla R.; Khanna V.K.; Kumar P.; Chaturvedi R.K.; Gupta K.C.; Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats. ACS Nano  2015,9(5),4850-4871","journal-title":"ACS Nano"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/nano8030178","volume":"8","author":"Lopalco A.","year":"2018","unstructured":"Lopalco A.; Cutrignelli A.; Denora N.; Lopedota A.; Franco M.; Laquintana V.; Transferrin functionalized liposomes loading dopamine HCl: Development and permeability studies across an in vitro model of human blood\u2013brain barrier. Nanomaterials  2018,8(3),178","journal-title":"Nanomaterials"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/1061186X.2016.1223676","volume":"25","author":"Huey R.","year":"2017","unstructured":"Huey R.; Hawthorne S.; McCarron P.; The potential use of rabies virus glycoprotein-derived peptides to facilitate drug delivery into the central nervous system: A mini review. J Drug Target  2017,25(5),379-385","journal-title":"J Drug Target"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2018.03.019","volume":"277","author":"Qu M.","year":"2018","unstructured":"Qu M.; Lin Q.; He S.; Wang L.; Fu Y.; Zhang Z.; Zhang L.; A brain targeting functionalized liposomes of the dopamine derivative N -3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson\u2019s disease. J Control Release  2018,277,173-182","journal-title":"J Control Release"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"Emre M.","year":"2004","unstructured":"Emre M.; Aarsland D.; Albanese A.; Byrne E.J.; Deuschl G.; De Deyn P.P.; Durif F.; Kulisevsky J.; van Laar T.; Lees A.; Poewe W.; Robillard A.; Rosa M.M.; Wolters E.; Quarg P.; Tekin S.; Lane R.; Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med  2004,351(24),2509-2518","journal-title":"N Engl J Med"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/10717544.2017.1309476","volume":"24","author":"Nageeb El-Helaly S.","year":"2017","unstructured":"Nageeb El-Helaly S.; Abd Elbary A.; Kassem M.A.; El-Nabarawi M.A.; Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies. Drug Deliv  2017,24(1),692-700","journal-title":"Drug Deliv"},{"key":"ref=124","first-page":"1","author":"McEneny-King A.","year":"2015","unstructured":"McEneny-King A.;  Metabolism, transport, and physiologically based pharmacokinetic modelling of novel tacrine derivatives  2015,1-6","journal-title":"Metabolism, transport, and physiologically based pharmacokinetic modelling of novel tacrine derivatives"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/08982104.2014.899369","volume":"24","author":"Corace G.","year":"2014","unstructured":"Corace G.; Angeloni C.; Malaguti M.; Hrelia S.; Stein P.C.; Brandl M.; Gotti R.; Luppi B.; Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride. J Liposome Res  2014,24(4),323-335","journal-title":"J Liposome Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"Colovi\u0107 M.B.","year":"2013","unstructured":"Colovi\u0107 M.B.; Krsti\u0107 D.Z.; Lazarevi\u0107-Pa\u0161ti T.D.; Bond\u017ei\u0107 A.M.; Vasi\u0107 V.M.; Acetylcholinesterase inhibitors: Pharmacology and toxicology. Curr Neuropharmacol  2013,11(3),315-335","journal-title":"Curr Neuropharmacol"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/DDDT.S113171","volume":"10","author":"Al Asmari A.K.","year":"2016","unstructured":"Al Asmari A.K.; Ullah Z.; Tariq M.; Fatani A.; Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Des Devel Ther  2016,10,205-215","journal-title":"Drug Des Devel Ther"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"Kocaadam B.","year":"2017","unstructured":"Kocaadam B.; \u015eanlier N.; Curcumin, an active component of turmeric ( Curcuma longa ), and its effects on health. Crit Rev Food Sci Nutr  2017,57(13),2889-2895","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","volume":"26","author":"Small G.W.","year":"2018","unstructured":"Small G.W.; Siddarth P.; Li Z.; Miller K.J.; Ercoli L.; Emerson N.D.; Martinez J.; Wong K.P.; Liu J.; Merrill D.A.; Chen S.T.; Henning S.M.; Satyamurthy N.; Huang S.C.; Heber D.; Barrio J.R.; Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: A double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry  2018,26(3),266-277","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10787-016-0297-9","volume":"25","author":"Singh S.","year":"2017","unstructured":"Singh S.; Kumar P.; Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats. Inflammopharmacology  2017,25(1),69-79","journal-title":"Inflammopharmacology"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/nu11071542","volume":"11","author":"du Preez R.","year":"2019","unstructured":"du Preez R.; Pahl J.; Arora M.; Ravi Kumar M.N.V.; Brown L.; Panchal S.K.; Low-dose curcumin nanoparticles normalise blood pressure in male wistar rats with diet-induced metabolic syndrome. Nutrients  2019,11(7),1542","journal-title":"Nutrients"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/1061186X.2016.1157883","volume":"24","author":"Liu W.","year":"2016","unstructured":"Liu W.; Zhai Y.; Heng X.; Che F.Y.; Chen W.; Sun D.; Zhai G.; Oral bioavailability of curcumin: Problems and advancements. J Drug Target  2016,24(8),694-702","journal-title":"J Drug Target"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"112233","DOI":"10.1016\/j.msec.2021.112233","volume":"127","author":"Kuo Y.C.","year":"2021","unstructured":"Kuo Y.C.; Ng I.W.; Rajesh R.; Glutathione- and apolipoprotein E-grafted liposomes to regulate mitogen-activated protein kinases and rescue neurons in Alzheimer\u2019s disease. Mater Sci Eng C  2021,127,112233","journal-title":"Mater Sci Eng C"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15407\/ubj88.03.083","volume":"88","author":"Sokolik V.","year":"2016","unstructured":"Sokolik V.; Shulga S.; Effect of curcumin on accumulation in mononuclear cells and secretion in incubation medium of A\u03b240 and cytokines under local excess of A\u03b242-homoaggregates. Ukr Biochem J  2016,88(3),83-91","journal-title":"Ukr Biochem J"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"566767","DOI":"10.3389\/fbioe.2020.566767","volume":"8","author":"Cascione M.","year":"2020","unstructured":"Cascione M.; De Matteis V.; Leporatti S.; Rinaldi R.; The new frontiers in neurodegenerative diseases treatment: Liposomal-based strategies. Front Bioeng Biotechnol  2020,8,566767","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2014.04.050","volume":"80","author":"Mourtas S.","year":"2014","unstructured":"Mourtas S.; Lazar A.N.; Markoutsa E.; Duyckaerts C.; Antimisiaris S.G.; Multifunctional nanoliposomes with curcumin\u2013lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem  2014,80,175-183","journal-title":"Eur J Med Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/foods9030374","volume":"9","author":"Batiha G.E.S.","year":"2020","unstructured":"Batiha G.E.S.; Beshbishy A.M.; Ikram M.; Mulla Z.S.; El-Hack M.E.A.; Taha A.E.; Algammal A.M.; Elewa Y.H.A.; The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods  2020,9(3),374","journal-title":"Foods"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12031-014-0400-x","volume":"55","author":"Magalingam K.B.","year":"2015","unstructured":"Magalingam K.B.; Radhakrishnan A.; Ramdas P.; Haleagrahara N.; Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson\u2019s disease. J Mol Neurosci  2015,55(3),609-617","journal-title":"J Mol Neurosci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bpc.2017.11.003","volume":"233","author":"Bonechi C.","year":"2018","unstructured":"Bonechi C.; Donati A.; Tamasi G.; Leone G.; Consumi M.; Rossi C.; Lamponi S.; Magnani A.; Protective effect of quercetin and rutin encapsulated liposomes on induced oxidative stress. Biophys Chem  2018,233,55-63","journal-title":"Biophys Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10571-019-00653-z","volume":"39","author":"Dubey S.K.","year":"2019","unstructured":"Dubey S.K.; Ram M.S.; Krishna K.V.; Saha R.N.; Singhvi G.; Agrawal M.; Ajazuddin ; Saraf S.; Saraf S.; Alexander A.; Recent expansions on cellular models to uncover the scientific barriers towards drug development for Alzheimer\u2019s disease. Cell Mol Neurobiol  2019,39(2),181-209","journal-title":"Cell Mol Neurobiol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/pharmaceutics5030457","volume":"5","author":"Mignet N.","year":"2013","unstructured":"Mignet N.; Seguin J.; Chabot G.; Bioavailability of polyphenol liposomes: A challenge ahead. Pharmaceutics  2013,5(3),457-471","journal-title":"Pharmaceutics"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/pharmaceutics15020421","volume":"15","author":"Zafar M.N.","year":"2023","unstructured":"Zafar M.N.; Abuwatfa W.H.; Husseini G.A.; Acoustically-activated liposomal nanocarriers to mitigate the side effects of conventional chemotherapy with a focus on emulsion-liposomes. Pharmaceutics  2023,15(2),421","journal-title":"Pharmaceutics"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1007\/s13346-023-01368-x","volume":"13","author":"Qian J.","year":"2023","unstructured":"Qian J.; Guo Y.; Xu Y.; Wang X.; Chen J.; Wu X.; Combination of micelles and liposomes as a promising drug delivery system: a review. Drug Deliv Transl Res  2023,13(11),2767-2789","journal-title":"Drug Deliv Transl Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/21691401.2023.2247036","volume":"51","author":"Pande S.","year":"2023","unstructured":"Pande S.; Liposomes for drug delivery: Review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artif Cells Nanomed Biotechnol  2023,51(1),428-440","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"104984","DOI":"10.1016\/j.supflu.2020.104984","volume":"165","author":"Maja L.","year":"2020","unstructured":"Maja L.; \u017deljko K.; Mateja P.; Sustainable technologies for liposome preparation. J Supercrit Fluids  2020,165,104984","journal-title":"J Supercrit Fluids"}],"container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249342585241230065557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238997\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249342585241230065557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:33:56Z","timestamp":1758267236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238997\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":145,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249342585241230065557","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}